Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  3,669,087 results for ""Drug Therapy""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy.

  • Authors : Heynemann S; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; Vanguru V

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology ; Lymphohistiocytosis, Hemophagocytic*/Lymphohistiocytosis, Hemophagocytic*/Lymphohistiocytosis, Hemophagocytic*/chemically induced

  • Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Apr; Vol. 20 (2), pp. 315-318. Date of Electronic Publication: 2022 Dec 23.Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.

  • Authors : Ju SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.; Lim JY

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Mar 22; Vol. 15, pp. 1336357. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Effects of allisartan-isoproxil-based combination antihypertensive regimen in hypertensive patients with microalbuminuria or hyperuricemia.

  • Authors : Sun N; Department of Hypertension, Peking University People's Hospital, Beijing, China.; Wang H

Subjects: Hypertension*/Hypertension*/Hypertension*/complications ; Hypertension*/Hypertension*/Hypertension*/drug therapy ; Hypertension*/Hypertension*/Hypertension*/chemically induced

  • Source: Journal of clinical hypertension (Greenwich, Conn.) [J Clin Hypertens (Greenwich)] 2024 Mar; Vol. 26 (3), pp. 241-250. Date of Electronic Publication: 2024 Feb 06.Publisher: Wiley Periodicals Inc Country of Publication: United States NLM ID: 100888554 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Add-on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: A prospective observational study.

  • Authors : Novitskaya Y; Department of Neurosurgery, Freiburg Epilepsy Center, Medical Center, University of Freiburg, Freiburg, Germany.; Schütz E

Subjects: Epilepsies, Partial*/Epilepsies, Partial*/Epilepsies, Partial*/drug therapy ; Drug Resistant Epilepsy*/Drug Resistant Epilepsy*/Drug Resistant Epilepsy*/drug therapy ; Drug Resistant Epilepsy*/Drug Resistant Epilepsy*/Drug Resistant Epilepsy*/chemically induced

  • Source: Epilepsia [Epilepsia] 2024 Mar; Vol. 65 (3), pp. 630-640. Date of Electronic Publication: 2024 Jan 10.Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Severity of Depressive Symptoms as an Independent Predictor of Sustained Virological Response During Treatment of Hepatitis C With Pegylated Interferon-α2a and Oral Ribavirin.

  • Authors : Pawłowski T; From the Division of Psychotherapy and Psychosomatic Medicine, Department of Psychiatry (Pawłowski, Małyszczak), Wrocław Medical University, Wrocław; Departments of Immunopathology of Infectious and Parasitic Diseases (Radkowski, Perlejewski) and Adults Infectious Diseases (Laskus), Medical University of Warsaw, Warsaw, Poland.

Subjects: Hepatitis C*/Hepatitis C*/Hepatitis C*/chemically induced ; Hepatitis C*/Hepatitis C*/Hepatitis C*/drug therapy ; Hepatitis C, Chronic*/Hepatitis C, Chronic*/Hepatitis C, Chronic*/drug therapy

  • Source: Psychosomatic medicine [Psychosom Med] 2024 Feb-Mar 01; Vol. 86 (2), pp. 124-128. Date of Electronic Publication: 2024 Jan 08.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0376505 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Neoadjuvant immunochemotherapy for pulmonary large-cell neuroendocrine carcinoma: case report.

  • Authors : Xu C; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Zhao G

Subjects: Carcinoma, Neuroendocrine*/Carcinoma, Neuroendocrine*/Carcinoma, Neuroendocrine*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy; Male

  • Source: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Apr 15; Vol. 19 (1), pp. 213. Date of Electronic Publication: 2024 Apr 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101265113 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-8090

Record details

Read More Add to Saved list
×
Academic Journal

Ultrastable Iodinated Oil-Based Pickering Emulsion Enables Locoregional Sustained Codelivery of Hypoxia Inducible Factor-1 Inhibitor and Anticancer Drugs for Tumor Combination Chemotherapy.

  • Authors : Li Z; Shenzhen Key Laboratory of Smart Healthcare Engineering, Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China.; Liu X

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2024 Apr 08; Vol. 10 (4), pp. 2270-2281. Date of Electronic Publication: 2024 Mar 27.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101654670 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.

  • Authors : Westbrook KJ; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Chilambi GS

Subjects: Endocarditis, Bacterial*/Endocarditis, Bacterial*/Endocarditis, Bacterial*/drug therapy ; Endocarditis, Bacterial*/Endocarditis, Bacterial*/Endocarditis, Bacterial*/microbiology ; Endocarditis*/Endocarditis*/Endocarditis*/drug therapy

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Apr 02; Vol. 79 (4), pp. 801-809.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Type 2 Diabetes Mellitus and Helicobacter pylori Eradication in a Clinical Population.

  • Authors : Sekaya G; Wang F; the Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Southern medical journal [South Med J] 2024 Apr; Vol. 117 (4), pp. 199-205.Publisher: Southern Medical Association Country of Publication: United States NLM ID: 0404522 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Metformin*/Metformin*/Metformin*/therapeutic use ; Sulfonylurea Compounds*

  • Source: Diabetes care [Diabetes Care] 2024 Apr 01; Vol. 47 (4), pp. 610-619.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  3,669,087 results for ""Drug Therapy""